...
首页> 外文期刊>Oncology reports >Capsaicin causes inactivation and degradation of the androgen receptor by inducing the restoration of miR-449a in prostate cancer
【24h】

Capsaicin causes inactivation and degradation of the androgen receptor by inducing the restoration of miR-449a in prostate cancer

机译:辣椒素通过诱导前列腺癌中miR-449a的恢复而引起雄激素受体的失活和降解

获取原文
获取原文并翻译 | 示例

摘要

Capsaicin, a novel antitumor agent extracted from chili peppers, has been proven to induce growth inhibition in various types of cancer including prostate cancer. However, the detailed mechanisms remain largely undiscovered. In the present study, we explored the regulation of the androgen receptor (AR) by capsaicin and further researched the mechanisms of their interaction in AR-positive prostate cancer cells. In the present study, cell viability was assessed by MTT assay. Cell cycle distribution was determined using flow cytometry. Expression levels of cyclin D1, miR-449a, AR and prostate-specific antigen (PSA) were assessed by quantitative real-time polymerase chain reaction or western blot analysis. To further confirm the relationship among miR-449a, AR and prostate cancer proliferation, miR-449a was overexpressed by a lentivirus in prostate cancer cells. We discovered that capsaicin prevented tumor proliferation and cell cycle progression through inactivation and degradation of AR. We also found that restoration of miR-449a induced by capsaicin treatment resulted in the inhibition of AR signaling. Finally, we demonstrated that increased expression of miR-449a sensitized prostate cancer to capsaicin treatment. Finally, our experimental results indicated that capsaicin negatively modulates the activity of AR at the mRNA and protein levels by restoring miR-449a profiling in prostate cancer. In addition, increased expression of miR-449a may facilitate the sensitivity of prostate cancer to capsaicin treatment. Thus, capsaicin may be developed as a novel anti-AR drug for the therapy of prostate cancer.
机译:辣椒素是一种从辣椒中提取的新型抗肿瘤药,已被证明可在包括前列腺癌在内的各种类型的癌症中诱导生长抑制。但是,详细的机制仍未发现。在本研究中,我们探讨了辣椒素对雄激素受体(AR)的调节作用,并进一步研究了它们在AR阳性前列腺癌细胞中相互作用的机制。在本研究中,通过MTT分析评估细胞活力。使用流式细胞术确定细胞周期分布。通过定量实时聚合酶链反应或蛋白质印迹分析评估细胞周期蛋白D1,miR-449a,AR和前列腺特异性抗原(PSA)的表达水平。为了进一步证实miR-449a,AR和前列腺癌增殖之间的关系,慢病毒在前列腺癌细胞中过表达miR-449a。我们发现辣椒素通过AR的失活和降解阻止了肿瘤的增殖和细胞周期的发展。我们还发现,辣椒素处理诱导的miR-449a的恢复导致AR信号传导的抑制。最后,我们证明了miR-449a的表达增加对辣椒素治疗敏感的前列腺癌。最后,我们的实验结果表明,辣椒素通过恢复前列腺癌中的miR-449a分析,在mRNA和蛋白质水平上负面调节AR的活性。此外,miR-449a的表达增加可能促进前列腺癌对辣椒素治疗的敏感性。因此,辣椒素可被开发为用于治疗前列腺癌的新型抗AR药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号